Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | SDCBP | O00560 | 3/20 | 0.41 |
| ▸ | SDC2 | P34741 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 1/20 | 0.38 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 2/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5689687 | 1.00 | PNMT (0.44) | PNMTNPC1RAB9ATYRSDCBP | |
| SCHEMBL22804044 | 1.00 | PNMT (0.44) | PNMTNPC1RAB9ATYRSDCBP | |
| SCHEMBL30762790 | 1.00 | PNMT (0.44) | PNMTNPC1RAB9ATYRSDCBP | |
| SCHEMBL31026357 | 0.96 | SDCBP (0.43) | PNMTNPC1RAB9ATYRSDCBP | |
| SCHEMBL29084932 | 0.96 | SDCBP (0.43) | PNMTNPC1RAB9ATYRSDCBP | |
| Valine SCHEMBL28455218 | 0.93 | PNMT (0.41) | PNMTNPC1RAB9ATYRSDCBP | |
| SCHEMBL30762664 | 0.89 | TYR (0.43) | PNMTNPC1RAB9ATYRMME | |
| SCHEMBL22804105 | 0.89 | TYR (0.43) | PNMTNPC1RAB9ATYRMME | |
| SCHEMBL9052782 | 0.89 | TYR (0.43) | PNMTNPC1RAB9ATYRMME | |
| SCHEMBL3727529 | 0.89 | TYR (0.43) | PNMTNPC1RAB9ATYRMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112159461-B | Synthesis method of cetrorelix | 开封明仁药业有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-113527416-A | Preparation method of nitroreductase responsive amino acid and tumor hypoxia fluorescent probe | 南开大学 | 2021-10-22 | — | — | CN | claimed |
| CN-112159461-A | Synthesis method of cetrorelix | 开封明仁药业有限公司 | 2021-01-01 | — | — | CN | claimed |
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-102702327-B | Solid-liquid phase synthesis method for alarelin acetate | GL BIOCHEM SHANGHAI CO LTD | 2013-10-30 | — | — | CN | claimed |
| CN-101224306-B | Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof | UNIV SUN YAT SEN | 2011-04-20 | — | — | CN | claimed |
| EP-4682168-A1 | ANTI-LIV-1 ANTIBODY AND ANTI-LIV-1 ANTIBODY-DRUG CONJUGATE, AND PHARMACEUTICAL USE THEREOF | BioRay Pharmaceutical Co., Ltd. (CN) | 2026-01-21 | — | — | EP | disclosed |
| CN-119350530-A | Preparation method of 2-chlorotrityl alcohol resin, 2-CTC resin and polypeptide solid phase | 江苏海普功能材料有限公司 | 2025-01-24 | — | — | CN | disclosed |
| WO-2024188339-A1 | ANTI-LIV-1 ANTIBODY AND ANTI-LIV-1 ANTIBODY-DRUG CONJUGATE, AND PHARMACEUTICAL USE THEREOF | 浙江博锐生物制药有限公司 | 2024-09-19 | — | — | WO | disclosed |
| CN-114920804-B | Cetrorelix synthesis process capable of being directly used for pilot scale amplification | 厦门胜泽泰医药科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118165078-A | Bacillus subtilis source antibacterial peptide NDYT-8 and application thereof | 华南理工大学 | 2024-06-11 | — | — | CN | disclosed |
| CN-114437714-B | Circular polarization luminescent material based on enantioselective co-assembly and application thereof | 中国科学院化学研究所 | 2023-09-29 | — | — | CN | disclosed |
| CN-112159461-B | Synthesis method of cetrorelix | 开封明仁药业有限公司 | 2023-03-10 | — | — | CN | disclosed |
| EP-0646596-B1 | Nucleic acid binding oligomers having C-branches for therapy and diagnosis | BAYER AG (DE) | 1999-05-26 | — | — | EP | disclosed |
| US-5849893-A | Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics | BAYER AKTIENGESELLSCHAFT (DE) | 1998-12-15 | — | — | US | disclosed |
| EP-0646596-A1 | Nucleic acid binding oligomers having C-branches for therapy and diagnosis | BAYER AG (DE) | 1995-04-05 | — | — | EP | disclosed |
| EP-0384523-B1 | New gem-diamino derivatives and their use in the synthesis of retro-inverso peptides | ENIRICERCHE SPA (IT) | 1994-06-01 | — | — | EP | disclosed |
| WO-1993023570-A1 | OLIGONUCLEOTIDES HAVING CONJUGATES ATTACHED AT THE 2'-POSITION OF THE SUGAR MOIETY | PHARMAGENICS, INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| US-5219988-A | GEM-DIAMINO DERIVATIVES AND THEIR USE IN THE SYNTHESIS OF RETRO-INVERSO PEPTIDES | ENIRICERCHE S.P.A. (IT) | 1993-06-15 | — | — | US | disclosed |
| EP-0384523-A2 | New gem-diamino derivatives and their use in the synthesis of retro-inverso peptides | ENIRICERCHE S.p.A. (IT) | 1990-08-29 | — | — | EP | disclosed |